Grovy India raises ₹15 cr from promoters in a deal equal to 27% of its market cap
The nano-cap real estate developer is selling up to 41.7 million shares at ₹36 each to promoter-group entities and a handful of public investors, a raise equivalent to more than a quarter of its current value.
— 2 earlier stories on Grovy India Ltd. →What's new
- Board approved a preferential issue of up to 41.7 million shares at ₹36 each, raising about ₹15 crore.
- Allottees include promoter-family members and several individual public investors.
- Authorised capital to be raised to ₹25 crore from ₹13.5 crore, doubling the headroom for future equity.
Why this matters
For a company valued at ₹56 crore, raising ₹15 crore is not routine fundraising; it is a 27% dilution at a discount to the market price. The list of buyers — promoter-family members alongside a few public investors — suggests the raise is as much about locking in insider capital as it is about funding projects. The simultaneous doubling of authorised capital signals more equity may be on the way.
What we're watching
- Whether the ₹36 issue price holds as a new support level for the stock.
- How quickly the ₹15 crore is deployed into the South Delhi luxury projects mentioned in analyst commentary.
- The shareholder vote at the July 8 AGM, where both the capital increase and the allotment require approval.
The full read
Grovy India, a nano-cap real estate developer, is raising ₹15 crore through a preferential allotment of up to 41.7 million shares at ₹36 each. The raise is equivalent to 27% of the company's ₹56 crore market capitalisation, an enormous chunk of dilution in a single round. The buyers are a mix of promoter-family members and a few public investors, which suggests the capital is meant to anchor the company's growth plans rather than chase a discount for short-term gain. Proceeds are earmarked for ongoing real estate projects, likely the luxury residential acquisitions in South Delhi that have defined Grovy's recent strategy. The board also doubled its authorised capital to ₹25 crore, creating the capacity for further equity expansion beyond this round. A final dividend of ₹0.10 per share was recommended. Both the capital increase and the allotment require shareholder approval at the July 8 AGM. The issue price is a modest discount to the market, and for a stock of this size, the concentration of buyers inside the promoter circle is the data point that matters.
Questions answered
- Why is a ₹15 crore raise material for Grovy India?
- Grovy has a market capitalisation of just ₹56 crore. A ₹15 crore infusion is equivalent to about 27% of that value, making it one of the largest single equity raises in the company's recent history. It materially alters the capital structure.
- At what price are the new shares being issued, and is that a good deal for the buyers?
- The shares are priced at ₹36 each, a modest discount to the prevailing market price. The list of buyers includes promoter-family members and several individual investors, suggesting the motive is strategic rather than purely financial.
- What does the doubling of authorised capital mean?
- Grovy plans to raise its authorised share capital from ₹13.5 crore to ₹25 crore. This creates the legal headroom for the company to issue significantly more equity in the future, beyond this ₹15 crore round.
- What will the money be used for?
- The company said proceeds will fund ongoing real estate projects and general corporate purposes. Analyst context links the raise to the company's recent luxury residential project acquisitions in South Delhi.
Story so far
All notes on GROVY →- 9 Jun 2026 · 5:08 PM IST Grovy India raises ₹15 cr from promoters in a deal equal to 27% of its market cap
- today Grovy India is swapping its CEO and CFO and installing a new chairperson.
- 13d ago Grovy India lands a luxury residential project in South Delhi